PortViewPortView
Dimension Therapeutics logo

Dimension Therapeutics (DMTX) Stock Analysis

NASDAQHealthcareBiotechnology

$5.95-0.42%
52-week range$5.95
$1.05$6.10

What Dimension Therapeutics does

Dimension Therapeutics, Inc. (NASDAQ: DMTX) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap
$0
P/E (TTM)
-2.67
EPS (TTM)
$-2.23
Beta
4.18
Dividend yield
0.00%
Revenue / share
$0.46
50-day avg
$5.31
200-day avg
$2.53
52-week high
$6.10
52-week low
$1.05

ETFs linked to DMTX

Broad-market and Healthcare sector ETFs an investor holding Dimension Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DMTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze DMTX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Dimension Therapeutics?
Dimension Therapeutics trades under the ticker DMTX on NASDAQ.
Which exchange is DMTX listed on?
DMTX is listed on NASDAQ.
What sector does Dimension Therapeutics operate in?
Dimension Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze DMTX in a portfolio?
PortView shows DMTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.